PHA SCR spike protein Cathepsin L
(Die Seite wurde neu angelegt: „{{up|PHA pharmacophore by screened target}} ---- Cathepsin L, C , B ---- {{tp|p=32468052|t=2020. Pancancer analysis of transmembrane protease serine 2 and cat…“)
Aktuelle Version vom 27. April 2021, 17:00 Uhr
| PHA pharmacophore by screened target |
Cathepsin L, C , B
32468052 2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.
32692176 2020. Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?
32841639 2020. Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2.
33137165 2020. The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors.
33158912 2020. Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L.
33290397 2020. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.
